FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

‘LONG Overdue’: Trump Calls for Ukraine to Oust Zelenskyy

Watch: El-Sayed Still Can’t Condemn Dead Ayatollah Khamenei, Man Who Killed and Oppressed His Own People

Wage growth lags inflation, making the affordability crisis feel even more acute

China is in bed with the world’s worst regimes

A new biography revisits ‘No Country for Old Men’ author Cormac McCarthy

Flock executive defends crime-fighting cameras as ACLU attorney questions company’s motives amid backlash

MAP IT: DOJ illegal voting crackdown sweeps 17 states as razor-thin elections face scrutiny

Delaware neighborhood on edge after masked men with apparent weapons knock on doors of homes

Trump says he’d ‘love’ to have Sen. John Fetterman as a Republican amid growing speculation

Trump says he will ‘make a decision’ on Pentagon’s plans to livestream Nidal Hasan’s firing squad execution

Toxicology reports reveal same controlled substances in 2 Ole Miss students found dead: court docs

President talks ‘Trump Ocean,’ trades jokes with Tennessee crowd as Kid Rock kicks off sprawling rally

Supreme Court climate case could bankrupt oil companies, send gas prices soaring, experts warn

Trump calls for Ukraine to replace Zelenskyy after clash over Russia diesel deal: ‘Get a new president’

Christa Pike discharged from hospital, returned to prison after botched execution, attorneys say

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”